"Imo if the clinical trials didn’t go so well they would have reported it early".
The trials have barely begun - with only 1 of 3 sites commenced and that site only in the early recruitment/pre-validation stage which is only about safety and algorithm refinement. This is a 12 month program and whether or not the trials "go so well" will not be known, imo, until mid-2023 at the earliest.
Having said that, I believe that, based on the pilot trial outcomes and the massive refinement work done since then, it is highly unlikely that the trials will not "go well".
HNY to all the faithful - both new and old!
Ann: EMVision Commences Clinical Trial, page-31
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EMV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.04 |
Change
0.055(2.77%) |
Mkt cap ! $173.5M | |||
| Open | High | Low | Value | Volume |
| $2.00 | $2.05 | $2.00 | $14.03K | 6.897K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 2171 | $2.03 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.05 | 5679 | 2 |
View Market Depth
| Last trade - 14.27pm 27/09/2024 (20 minute delay) ? |
| EMV (ASX) Chart |